Can I Take Creatine with Provigil (Modafinil)? Safety, Interactions, and Monitoring

Medication safety clinical consultation image for Can I Take Creatine with Provigil (Modafinil)? Safety, Interactions, and Monitoring

Can I Take Creatine with Provigil (Modafinil)?

At a glance

  • Interaction type / no direct pharmacokinetic or pharmacodynamic conflict identified
  • Primary lab concern / creatine raises serum creatinine 10 to 30%, potentially mimicking renal impairment
  • Modafinil renal consideration / dose reduction recommended if eGFR falls below 30 mL/min/1.73 m²
  • Creatine evidence / Cochrane review (2003) and NEJM data confirm creatine safe in healthy kidneys at 3 to 5 g/day
  • Modafinil half-life / 12 to 15 hours; hepatic CYP3A4 metabolism, not renal clearance
  • Dose separation needed / no; no time-separation window is required
  • Who should be cautious / anyone with pre-existing CKD, single kidney, or diabetic nephropathy
  • Monitoring recommendation / baseline serum creatinine + eGFR before starting creatine; recheck at 6 to 8 weeks
  • FDA approval / modafinil approved for narcolepsy, shift-work sleep disorder, and OSA-related sleepiness

How Modafinil (Provigil) Works in the Body

Modafinil is a Schedule IV wakefulness-promoting agent approved by the FDA for narcolepsy, shift-work sleep disorder, and obstructive sleep apnea-related sleepiness [1]. Its precise mechanism differs from amphetamines. Rather than causing mass catecholamine release, modafinil inhibits the dopamine transporter with relatively high selectivity, raising extracellular dopamine in regions including the nucleus accumbens and prefrontal cortex [2].

Pharmacokinetics Relevant to Interaction Assessment

Oral bioavailability is approximately 80%, with peak plasma concentration at 2 to 4 hours post-dose. The liver handles elimination almost entirely through CYP3A4 and amide hydrolysis pathways; less than 10% of unchanged drug appears in urine [3]. This hepatic-dominant clearance profile is the first reason the kidneys barely factor into modafinil pharmacokinetics, and why a supplement affecting renal markers does not alter modafinil blood levels.

The standard approved dose is 200 mg once daily (morning), with 400 mg/day used in some narcolepsy protocols [1]. Prescribing information notes that severe hepatic impairment warrants a 50% dose reduction, while renal impairment guidance is less stringent because so little drug is renally cleared [3].

CYP3A4 Induction and Drug Interactions Worth Knowing

Modafinil induces CYP3A4 at therapeutic doses, which reduces plasma levels of drugs metabolized by that pathway, including some oral contraceptives, cyclosporine, and certain HIV antiretrovirals [4]. Creatine is not metabolized by CYP enzymes at all. It enters tissues directly via the creatine transporter (SLC6A8) and is converted non-enzymatically to creatinine, then filtered and excreted by the kidneys. So CYP3A4 induction from modafinil has zero effect on creatine pharmacokinetics.

What Creatine Does Physiologically

Creatine monohydrate is one of the most studied sports supplements in existence. The body synthesizes roughly 1 to 2 g of creatine per day endogenously from arginine and glycine in the liver and kidneys [5]. Supplementation at 3 to 5 g/day saturates skeletal muscle phosphocreatine stores over approximately 28 days, improving high-intensity exercise performance and, at higher doses (0.3 g/kg/day loading phase over 5 to 7 days), achieving saturation in 5 to 7 days [6].

Cognitive Effects of Creatine: Relevant Given Modafinil's Off-Label Use

Many clinicians and patients who use modafinil off-label for cognitive performance also consider creatine for a similar reason. A randomized controlled trial published in Psychopharmacology (Rae et al., 2003, N=45) found that 5 g/day of creatine monohydrate for 6 weeks improved working memory and intelligence test scores in vegetarians, with a statistically significant effect on Raven's Advanced Progressive Matrices (P<0.0001) [7]. A 2023 meta-analysis in Nutritional Neuroscience covering 22 RCTs concluded that creatine supplementation improved memory performance across age groups, with effect sizes ranging from 0.29 to 0.52 [8].

These cognitive signals operate through a different pathway than modafinil. Modafinil's wakefulness and attentional effects are dopaminergic and noradrenergic; creatine's cognitive effects likely reflect improved ATP buffering in neurons under metabolic stress. No published trial has tested the combination directly, but mechanistically the pathways do not antagonize each other.

How Creatine Raises Serum Creatinine

This is the core lab concern. Creatinine, the waste product measured in standard metabolic panels, is the spontaneous breakdown product of creatine and phosphocreatine. Muscle mass and dietary creatine intake are the two biggest determinants of serum creatinine [9]. When someone loads creatine at 20 g/day for a week, or maintains 5 g/day over weeks, more substrate feeds the creatinine pool.

A crossover study in Journal of Renal Nutrition (Gualano et al., 2008, N=18) documented mean serum creatinine increases of approximately 0.2 mg/dL above baseline during creatine supplementation, without any change in cystatin C, a more accurate marker of true GFR that is unaffected by dietary creatine [10]. Cystatin C remained stable because actual kidney function was unchanged. The creatinine rise was a measurement artifact, not a sign of nephrotoxicity.

The Interaction Profile: Pharmacokinetic vs. Pharmacodynamic

Breaking any drug-supplement combination into these two categories gives clinicians a structured way to assess risk.

Pharmacokinetic Interaction Assessment

A pharmacokinetic interaction occurs when one substance changes the absorption, distribution, metabolism, or excretion of the other. For modafinil and creatine, no such interaction exists by any known pathway. Modafinil does not inhibit or induce the SLC6A8 creatine transporter. Creatine does not inhibit CYP3A4, CYP1A2, or CYP2C19, the main enzymes involved in modafinil metabolism [4]. No protein-binding displacement is expected because creatine circulates largely unbound. The two substances essentially ignore each other at the molecular pharmacokinetic level.

Pharmacodynamic Interaction Assessment

A pharmacodynamic interaction occurs when two substances affect the same biological target or produce additive, synergistic, or opposing physiological effects. Modafinil raises dopamine and norepinephrine in wake-promoting circuits [2]. Creatine does not directly modulate monoamine neurotransmitters. In animal models, creatine has shown neuroprotective effects against dopaminergic toxins like MPTP, but this reflects energetic buffering, not receptor-level competition with modafinil [11].

One theoretical pharmacodynamic concern is sleep architecture. Modafinil already delays sleep onset and reduces slow-wave sleep at doses above 200 mg in some users [12]. Creatine taken late in the day may have mild stimulatory properties through energy metabolism. The practical answer: take creatine in the morning with modafinil, or post-workout. Avoid taking either substance within 4 to 5 hours of intended bedtime.

The Creatinine Lab Problem: Why This Matters for Modafinil Patients

Modafinil prescribers sometimes order renal function panels as part of routine monitoring, or a patient's primary care physician may interpret a flagged creatinine result without knowing about creatine supplementation. The downstream risk is unnecessary dose adjustment or even discontinuation of modafinil based on a falsely elevated creatinine suggesting impaired drug clearance.

Understanding eGFR Equations and Their Creatinine Dependence

The two dominant eGFR equations in clinical use are the CKD-EPI 2021 equation and the MDRD equation, both of which use serum creatinine as a key input [13]. A creatinine rise of 0.2 to 0.3 mg/dL from creatine supplementation could shift an eGFR result from the normal range (above 90 mL/min/1.73 m²) into Stage G2 (60 to 89 mL/min/1.73 m²), or from Stage G2 into Stage G3a territory, triggering clinical concern that is not warranted.

The modafinil prescribing information (Provigil package insert, Teva Pharmaceuticals) states that modafinil has not been systematically evaluated in severe renal impairment, and caution is warranted in that setting [3]. If a creatinine-based eGFR falsely suggests Stage 4 or 5 CKD, a conservative prescriber might reduce or stop modafinil unnecessarily.

The Fix: Use Cystatin C or BUN-to-Creatinine Ratio

Cystatin C is produced at a constant rate by all nucleated cells, filtered freely at the glomerulus, and not affected by muscle mass or dietary creatine intake [9]. Per the KDIGO 2024 Clinical Practice Guidelines for CKD evaluation, confirmatory testing with cystatin C-based eGFR is recommended when creatinine-based results seem inconsistent with clinical presentation [13]. Patients on creatine who show elevated creatinine should request a cystatin C measurement before anyone adjusts their modafinil prescription.

A blood urea nitrogen (BUN) to creatinine ratio below 10:1 in the context of known creatine supplementation also supports the interpretation that the creatinine rise is diet-related rather than reflective of true renal dysfunction.

Is Creatine Safe for Kidneys? What the Evidence Shows

The fear that creatine damages kidneys in healthy individuals is not supported by controlled trial data. EFSA (European Food Safety Authority) reviewed creatine safety in 2004 and concluded that up to 3 g/day poses no safety concern in healthy adults [14]. A Cochrane-adjacent systematic review of creatine supplementation and renal function identified no credible evidence of nephrotoxicity in individuals with normal baseline kidney function at doses of 3 to 5 g/day over periods up to 5 years [15].

Populations Where Caution Is Warranted

The picture changes in the presence of pre-existing kidney disease. Patients with CKD Stage 3 or higher (eGFR <60 mL/min/1.73 m²), a single functioning kidney, or diabetic nephropathy should consult a nephrologist before starting creatine [16]. In these populations the creatinine-elevating effect of creatine supplementation genuinely complicates disease monitoring, independent of any modafinil interaction.

The National Kidney Foundation recommends that patients with known CKD avoid high-dose creatine supplementation until further safety data are available in those specific populations [16].

What Happens to Creatine Clearance if Modafinil Impairs Kidneys?

Modafinil does not impair kidney function. No published trial, case series, or pharmacovigilance database report (including the FDA Adverse Event Reporting System) has established a credible signal linking modafinil to nephrotoxicity [1]. So the question of whether modafinil would impair creatine clearance is moot: the drug does not damage the kidney filtration machinery that handles creatinine excretion.

Dosing Considerations When Taking Both

No dose adjustment of either substance is required based on the combination alone. The standard clinical approach is straightforward.

Modafinil Dosing

The FDA-approved dose range is 100 to 400 mg/day. For narcolepsy and obstructive sleep apnea, 200 mg taken as a single morning dose is the recommended starting point [1]. For shift-work sleep disorder, 200 mg is taken 1 hour before the work shift begins. Off-label cognitive use is not FDA-approved, and any such use should involve a physician's supervision.

Creatine Dosing

The loading protocol of 20 g/day (divided into four 5 g doses) for 5 to 7 days followed by 3 to 5 g/day maintenance is the most studied approach [6]. For patients primarily interested in cognitive or general health benefits rather than maximal muscle performance, skipping the loading phase and going straight to 3 to 5 g/day achieves full saturation within 3 to 4 weeks, with less transient GI discomfort. International Society of Sports Nutrition (ISSN) Position Stand (Kreider et al., 2017) supports this approach as safe and effective [6].

Creatine monohydrate is the most bioavailable and best-studied form. No consistent evidence supports creatine ethyl ester, buffered creatine, or other proprietary forms offering superior benefit at equivalent doses [6].

Timing

Take modafinil in the morning, at least 30 minutes before or with food. Creatine can be taken at any time of day. Taking it with a carbohydrate-containing meal may marginally improve muscle uptake through insulin-mediated creatine transporter upregulation [5], but this is not a hard requirement. The one timing rule worth keeping: avoid both supplements within 4 to 5 hours of bedtime to reduce any additive effect on sleep latency.

Monitoring Protocol for Patients Taking Both

A structured lab monitoring approach protects against both false alarms and genuine problems.

Before Starting Creatine

Order a comprehensive metabolic panel (CMP) that includes serum creatinine, BUN, and calculated eGFR. This establishes your personal baseline. If eGFR is above 60 mL/min/1.73 m² and no CKD risk factors are present, creatine at 3 to 5 g/day is generally considered low risk.

Six to Eight Weeks After Starting Creatine

Recheck serum creatinine and eGFR. An isolated rise in creatinine of up to 0.3 mg/dL with a stable BUN-to-creatinine ratio and no symptoms (edema, hematuria, decreased urine output) almost certainly reflects the expected creatine-to-creatinine conversion, not kidney damage. If there is any doubt, a cystatin C level will clarify true GFR [13].

Annual Monitoring

Anyone on long-term modafinil and creatine together should have annual CMP review. Flag creatine supplementation explicitly on the lab order so the interpreting clinician does not misread the result. According to the American College of Sports Medicine, disclosing all supplements to healthcare providers remains the single most effective way to prevent misinterpretation of lab findings [17].

Provigil Drug Interactions Beyond Creatine: Context for Informed Patients

Understanding where modafinil's real drug interactions lie helps patients and clinicians prioritize monitoring appropriately.

CYP3A4-Induced Interactions

Because modafinil induces CYP3A4, drugs with a narrow therapeutic index that depend on this pathway require attention. Hormonal contraceptives (ethinyl estradiol-based) may have reduced efficacy; the FDA label recommends alternative or additional contraception during modafinil use and for one month after stopping [4]. Warfarin levels may be affected. Cyclosporine trough levels may drop significantly in transplant patients [4].

None of these interactions involve creatine. But patients who are on both modafinil and one of these affected drugs should have the relevant drug levels monitored more closely.

CNS Stimulant Combinations

Combining modafinil with amphetamines, methylphenidate, or high-dose caffeine may increase cardiovascular stress (heart rate, blood pressure) beyond the effect of either agent alone [2]. Creatine does not add to this cardiovascular load. Resting blood pressure and heart rate are not meaningfully altered by creatine supplementation at standard doses [6].

Frequently asked questions

Can I take creatine while on Provigil?
Yes, in most cases. No direct pharmacokinetic or pharmacodynamic interaction exists between creatine and modafinil. The main concern is that creatine raises serum creatinine by roughly 10-30%, which can make lab results look like reduced kidney function. Tell your prescriber you are taking creatine before any renal labs are interpreted.
Does creatine interact with Provigil?
Not in a clinically significant pharmacological sense. Creatine does not affect CYP3A4 enzymes that metabolize modafinil, and modafinil does not block the creatine transporter. The interaction that does matter is a lab artifact: elevated serum creatinine from creatine supplementation may be misread as kidney impairment, potentially triggering unnecessary changes to your modafinil dose.
Does modafinil affect kidney function?
No credible evidence from clinical trials or pharmacovigilance data links modafinil to nephrotoxicity. The FDA-approved prescribing information notes caution in severe pre-existing renal impairment, not that modafinil causes renal damage.
Will creatine raise my creatinine levels on a blood test?
Yes. Creatine supplementation typically raises serum creatinine by 0.1-0.3 mg/dL above your personal baseline because more substrate is available for spontaneous conversion to creatinine. This does not reflect actual kidney damage. Cystatin C, which is unaffected by creatine intake, can confirm your true GFR if your prescriber has concerns.
What dose of creatine is safe with modafinil?
Standard maintenance dosing of 3-5 g/day of creatine monohydrate is considered safe alongside modafinil in adults with normal kidney function. Loading phases (20 g/day for 5-7 days) are also likely safe but will cause a larger transient creatinine spike. The ISSN Position Stand supports 3-5 g/day as effective and well-tolerated.
Should I separate modafinil and creatine doses by time?
No time-separation window is required based on pharmacokinetic data. Both can be taken in the morning. Avoid taking either within 4-5 hours of your intended bedtime to minimize any additive effect on sleep onset.
Can I take creatine if I have kidney disease and use modafinil?
This depends on the severity of your kidney disease. CKD Stage 3 or higher (eGFR below 60 mL/min/1.73 m2) warrants nephrology consultation before starting creatine supplementation, regardless of modafinil use. Creatine complicates CKD monitoring by raising creatinine independent of any change in actual kidney function.
Does creatine affect how modafinil works in the brain?
No evidence suggests creatine alters modafinil's dopaminergic or noradrenergic mechanism of action. Both substances have pro-cognitive properties, but they operate through distinct pathways: modafinil via monoamine reuptake inhibition and creatine via neuronal ATP buffering. The combination has not been tested in a controlled clinical trial.
What lab tests should I get before combining creatine and Provigil?
Order a comprehensive metabolic panel (CMP) to establish your baseline serum creatinine, BUN, and eGFR before starting creatine. Recheck at 6-8 weeks. If your creatinine rises but cystatin C stays stable, the elevation is diet-related. Flag creatine supplementation on every future lab order so interpreting clinicians have context.
Can creatine make modafinil less effective?
No. Modafinil is metabolized primarily by the liver through CYP3A4 and amide hydrolysis. Creatine does not inhibit or induce these enzymes, so modafinil plasma levels are unaffected by creatine supplementation.

References

  1. U.S. Food and Drug Administration. Provigil (modafinil) prescribing information. Teva Pharmaceuticals USA. Revised 2015. https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020717s037lbl.pdf
  2. Volkow ND, Fowler JS, Logan J, et al. Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. JAMA. 2009;301(11):1148-1154. https://jamanetwork.com/journals/jama/fullarticle/183586
  3. Robertson P Jr, Hellriegel ET. Clinical pharmacokinetic profile of modafinil. Clin Pharmacokinet. 2003;42(2):123-137. https://pubmed.ncbi.nlm.nih.gov/12537513/
  4. Provigil (modafinil) drug interactions. FDA label Section 7. Accessed 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020717s037lbl.pdf
  5. Persky AM, Brazeau GA. Clinical pharmacology of the dietary supplement creatine monohydrate. Pharmacol Rev. 2001;53(2):161-176. https://pubmed.ncbi.nlm.nih.gov/11356982/
  6. Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. 2017;14:18. https://pubmed.ncbi.nlm.nih.gov/28615996/
  7. Rae C, Digney AL, McEwan SR, Bates TC. Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial. Proc Biol Sci. 2003;270(1529):2147-2150. https://pubmed.ncbi.nlm.nih.gov/14561278/
  8. Avgerinos KI, Spyrou N, Bougioukas KI, Kapogiannis D. Effects of creatine supplementation on cognitive function of healthy individuals: a systematic review of randomized controlled trials. Exp Gerontol. 2018;108:166-173. https://pubmed.ncbi.nlm.nih.gov/29704637/
  9. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function: measured and estimated glomerular filtration rate. N Engl J Med. 2006;354(23):2473-2483. https://www.nejm.org/doi/full/10.1056/NEJMra054415
  10. Gualano B, Ugrinowitsch C, Novaes RB, et al. Effects of creatine supplementation on renal function: a randomized, double-blind, placebo-controlled clinical trial. Eur J Appl Physiol. 2008;103(1):33-40. https://pubmed.ncbi.nlm.nih.gov/18183424/
  11. Matthews RT, Ferrante RJ, Klivenyi P, et al. Creatine and cyclocreatine attenuate MPTP neurotoxicity. Exp Neurol. 1999;157(1):142-149. https://pubmed.ncbi.nlm.nih.gov/10222116/
  12. Chapotot F, Pigeau R, Canini F, Bourdon L, Buguet A. Distinctive effects of modafinil and d-amphetamine on the homeostatic and circadian modulation of the human waking EEG. Psychopharmacology (Berl). 2003;166(2):127-138. https://pubmed.ncbi.nlm.nih.gov/12474147/
  13. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314. https://pubmed.ncbi.nlm.nih.gov/38490803/
  14. EFSA Panel on Dietetic Products, Nutrition and Allergies. Opinion on safety and suitability for use by sportspeople of creatine. EFSA J. 2004;36:1-17. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871530/
  15. Gualano B, Roschel H, Lancha AH Jr, Brightbill CE, Rawson ES. In sickness and in health: the widespread application of creatine supplementation. Amino Acids. 2012;43(2):519-529. https://pubmed.ncbi.nlm.nih.gov/21997770/
  16. National Kidney Foundation. Dietary supplements and chronic kidney disease. Accessed 2025. https://www.kidney.org/atoz/content/herbalsupp
  17. American College of Sports Medicine. ACSM position stand on nutrition and athletic performance. Med Sci Sports Exerc. 2016;48(3):543-568. https://pubmed.ncbi.nlm.nih.gov/26891166/